Efficacy of Er:YAG Laser in Decontamination of Dental Implants: An In-Vitro Study

Sponsor
Tufts University School of Dental Medicine (Other)
Overall Status
Recruiting
CT.gov ID
NCT03100435
Collaborator
(none)
8
1
4
19.4
0.4

Study Details

Study Description

Brief Summary

The American Association of Oral and Maxillofacial Surgeons estimated that 69% of adults ages 35 to 44 have lost at least one permanent tooth. Dental implants have revolutionized dentistry by providing tooth-like replacement for missing teeth and a solution that is predictable with long-term success..

After the implant is placed, natural bacteria from the mouth can develop around implants just like around natural teeth. Studies have shown that bacterial contamination can cause peri-implantitis- gum disease or inflammation around the implant, eventually leading to bone loss. Removing bacteria from dental implant surfaces can prevent peri-implantitis, and surface debridement constitutes the basis of treatment of peri-implant disease.

Typically, mechanical hand instrumentation using curettes to remove biofilm and calculus is the main basis for periodontal therapy. However, total debridement is difficult, and the hand tools may damage the surface of the implant and making it more plaque retentive. Studies have shown that mechanical non-surgical therapy alone is not sufficient to treat peri-implantitis.

There is evidence that a dental laser may be an effective method to remove bacteria from implant surfaces, with less damage to the surface. One type of dental laser, Er:YAG, appears optimal for implant decontamination as the Er:YAG laser energy is primarily absorbed by water, resulting in vaporization of bacteria and minimal surface alterations on the implant surface.The aim of this study is to evaluate the efficiency of biofilm decontamination of Er:YAG laser compared to carbon fiber curette.

Condition or Disease Intervention/Treatment Phase
  • Device: Er:YAG Laser
  • Other: Carbon Fiber Curette
N/A

Detailed Description

The aim of this study is to compare the amount of residual biofilm on titanium discs after decontamination with Er:YAG laser and carbon fiber curette.

In the first phase of the study, custom mouth guards that holds multiple titanium discs will be fabricated. Experimental subjects will be instructed to wear this mouth guard for 72 hours, during which time a natural bacterial biofilm will form on the disc surfaces.

The second phase of the study will be performed ex vivo after collecting the discs from the subjects. Discs retrieved from each mouth guard will be randomized over the 4 treatment groups, so that each subject will contribute two discs to each treatment group: 1) Er:YAG laser, 2) carbon fiber curette, 3) combination of carbon fiber curette and Er:YAG laser, and 4) no treatment (control). The biofilm will be stained and the residual biofilm will be visualized under fluorescence microscopy. Statistical methods will be used to determine the significance of each treatment modality.

The primary outcome of the study is the percent area of the titanium disc covered by biofilm.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
8 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
All participants will wear a mouth guard holding 8 titanium discs for 3 days, during which time a natural bacterial biofilm will form on the disc surfaces. After 3 days, the discs will be removed from the mouthguard, and treated ex vivo with different decontamination methods.All participants will wear a mouth guard holding 8 titanium discs for 3 days, during which time a natural bacterial biofilm will form on the disc surfaces. After 3 days, the discs will be removed from the mouthguard, and treated ex vivo with different decontamination methods.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Efficacy of Er:YAG Laser in Decontamination of Dental Implants: An In-Vitro Study
Actual Study Start Date :
Apr 20, 2017
Anticipated Primary Completion Date :
Dec 1, 2018
Anticipated Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Er:YAG Laser

Er:YAG Laser only

Device: Er:YAG Laser
Titanium disks will be decontaminated ex-vivo with the Er:YAG laser.

Active Comparator: Carbon Fiber Curette

Carbon fiber curette only

Other: Carbon Fiber Curette
Titanium disks will be decontaminated ex-vivo with carbon fiber curettes

Experimental: Er:YAG Laser + Carbon Fiber Curette

Combination of Er:YAG Laser and carbon fiber curette

Device: Er:YAG Laser
Titanium disks will be decontaminated ex-vivo with the Er:YAG laser.

Other: Carbon Fiber Curette
Titanium disks will be decontaminated ex-vivo with carbon fiber curettes

No Intervention: No Treatment

No treatment (control)

Outcome Measures

Primary Outcome Measures

  1. Percent Bacteria Biofilm [3 days]

    Percent area of the titanium disc covered by bacteria biofilm

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Presence of enough teeth to support the mouth guard.

  • Subjects diagnosed with clinical health, gingivitis, or slight chronic periodontitis defined as periodontal inflammation with slight (1-2mm) attachment loss.

Exclusion Criteria:
  • Subjects with insufficient dental support for the mouth guard

  • Subjects diagnosed with moderate or severe chronic periodontitis.

  • Subjects with known allergy to acrylic or titanium.

  • Subjects who smoke cigarettes, cigars, snuff tobacco, or any other form of smoking.

  • Subjects with a history of antibiotic treatment within the last six months.

  • Subjects with contraindications to wearing a mouth guard, such as chronic obstructive pulmonary disease or severe sleep apnea.

  • Subjects with uncontrolled or debilitating medical conditions, including but not limited to subjects with uncontrolled diabetes, hematologic disorders, cancers, immunosuppression, severe cardiovascular disease, or uncontrolled thyroid disease

  • Subjects that are currently pregnant according to self-report

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tufts University School of Dental Medicine Boston Massachusetts United States 02111

Sponsors and Collaborators

  • Tufts University School of Dental Medicine

Investigators

  • Principal Investigator: Robert Gyurko, DMD, PhD, TUSDM

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tufts University School of Dental Medicine
ClinicalTrials.gov Identifier:
NCT03100435
Other Study ID Numbers:
  • 12380
First Posted:
Apr 4, 2017
Last Update Posted:
Jan 11, 2018
Last Verified:
Jan 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2018